Pfizer (Germany) Performance

PFE Stock  EUR 23.17  0.41  1.80%   
Pfizer has a performance score of 6 on a scale of 0 to 100. The company holds a Beta of 0.005, which implies not very significant fluctuations relative to the market. As returns on the market increase, Pfizer's returns are expected to increase less than the market. However, during the bear market, the loss of holding Pfizer is expected to be smaller as well. Pfizer Inc right now holds a risk of 1.51%. Please check Pfizer Inc jensen alpha, sortino ratio, and the relationship between the standard deviation and total risk alpha , to decide if Pfizer Inc will be following its historical price patterns.

Risk-Adjusted Performance

Mild

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Pfizer Inc are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Pfizer may actually be approaching a critical reversion point that can send shares even higher in March 2026. ...more
Forward Dividend Yield
0.0643
Payout Ratio
0.7407
Forward Dividend Rate
1.46
Ex Dividend Date
2026-01-23
1
Pfizer Stock After Hours on Dec. 15, 2025 What Moved Shares Todayand What to Watch Before Tuesdays Open - ts2.tech
12/15/2025
2
Heres What Analysts Think About Pfizer Inc. - Yahoo Finance
12/29/2025
3
Gateway Investment Advisers LLC Lowers Stock Position in Pfizer Inc. PFE - MarketBeat
01/06/2026
4
Pfizer Buyer Beware, The Risk Outweighs The Reward - Seeking Alpha
01/30/2026
5
Pfizer Stock Falls After Solid Earnings. Whats Troubling Wall Street. - Barrons
02/03/2026
6
Pfizer Inc. Announces FDAs Grant of Priority Review for HYMPAVZI sBLA - Finviz
02/10/2026
  

Pfizer Relative Risk vs. Return Landscape

If you would invest  2,174  in Pfizer Inc on November 13, 2025 and sell it today you would earn a total of  143.00  from holding Pfizer Inc or generate 6.58% return on investment over 90 days. Pfizer Inc is currently producing 0.1175% returns and takes up 1.5132% volatility of returns over 90 trading days. Put another way, 13% of traded stocks are less volatile than Pfizer, and 98% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Pfizer is expected to generate 1.95 times more return on investment than the market. However, the company is 1.95 times more volatile than its market benchmark. It trades about 0.08 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of risk.

Pfizer Target Price Odds to finish over Current Price

The tendency of Pfizer Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 23.17 90 days 23.17 
near 1
Based on a normal probability distribution, the odds of Pfizer to move above the current price in 90 days from now is near 1 (This Pfizer Inc probability density function shows the probability of Pfizer Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Pfizer has a beta of 0.005 indicating as returns on the market go up, Pfizer average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Pfizer Inc will be expected to be much smaller as well. Additionally Pfizer Inc has an alpha of 0.1939, implying that it can generate a 0.19 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Pfizer Price Density   
       Price  

Predictive Modules for Pfizer

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Pfizer Inc. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
21.7023.2124.72
Details
Intrinsic
Valuation
LowRealHigh
20.8526.1927.70
Details

Pfizer Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Pfizer is not an exception. The market had few large corrections towards the Pfizer's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Pfizer Inc, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Pfizer within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.19
β
Beta against Dow Jones0.01
σ
Overall volatility
0.56
Ir
Information ratio 0.07

Pfizer Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Pfizer for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Pfizer Inc can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Pfizer Inc has accumulated €6.95 Billion in debt which can lead to volatile earnings
About 68.0% of the company shares are owned by institutional investors
Latest headline from news.google.com: Pfizer Inc. Announces FDAs Grant of Priority Review for HYMPAVZI sBLA - Finviz

Pfizer Fundamentals Growth

Pfizer Stock prices reflect investors' perceptions of the future prospects and financial health of Pfizer, and Pfizer fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Pfizer Stock performance.

About Pfizer Performance

By analyzing Pfizer's fundamental ratios, stakeholders can gain valuable insights into Pfizer's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Pfizer has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Pfizer has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 209.11  238.48 
Return On Tangible Assets 0.08  0.10 
Return On Capital Employed 0.11  0.22 
Return On Assets 0.04  0.04 
Return On Equity 0.10  0.10 

Things to note about Pfizer Inc performance evaluation

Checking the ongoing alerts about Pfizer for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Pfizer Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Pfizer Inc has accumulated €6.95 Billion in debt which can lead to volatile earnings
About 68.0% of the company shares are owned by institutional investors
Latest headline from news.google.com: Pfizer Inc. Announces FDAs Grant of Priority Review for HYMPAVZI sBLA - Finviz
Evaluating Pfizer's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Pfizer's stock performance include:
  • Analyzing Pfizer's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Pfizer's stock is overvalued or undervalued compared to its peers.
  • Examining Pfizer's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Pfizer's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Pfizer's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Pfizer's stock. These opinions can provide insight into Pfizer's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Pfizer's stock performance is not an exact science, and many factors can impact Pfizer's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Pfizer Stock analysis

When running Pfizer's price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments